Steven Horwitz, MD, Discusses Critical Trials in PTCL

By Blood Cancer Talks - Last Updated: August 31, 2023

In this episode of “Blood Cancer Talks,” the hosts are joined by Dr. Horwitz of the Memorial Sloan Kettering Cancer Center to discuss peripheral T-cell lymphoma (PTCL).

Dr. Horwitz and the hosts specifically focus on PTCL–not otherwise specified, angioimmunoblastic T-cell lymphoma (AITL), and anaplastic large cell lymphoma (ALCL). They discuss the ECHELON-2 randomized trial of CHOP versus BV-CHP in CD30-positive PTCL and the phase III Ro-CHOP study of romidepin-CHOP versus CHOP.

They also highlight a randomized controlled trial that compared autologous and allogeneic hemopoietic stem cell transplantation as part of frontline therapy in patients with poor-risk PTCL. Additionally, they discuss a phase II biomarker-driven study of ruxolitinib in T-cell lymphomas and the JACKPOT8 study.

This podcast originally appeared on Blood Cancer Talks.

What are the Controversies Surrounding MRD in Blood Cancers?

What are the Risk Factors, Treatment Options for Essential Thrombocythemia?

HMAs Are ‘Cornerstone’ in High-Risk MDS Treatment, Says Jamile Shammo, MD

Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL

Dr. Samer Al Hadidi Discusses CAR-T MM Data Presented at the FDA ODAC Meeting

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer

Steven Horwitz, MD, Discusses Critical Trials in PTCL

Related